Literature DB >> 24555636

Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging.

Matthew S Davenport1, Shokoufeh Khalatbari, Peter S C Liu, Katherine E Maturen, Ravi K Kaza, Ashish P Wasnik, Mahmoud M Al-Hawary, Daniel I Glazer, Erica B Stein, Jeet Patel, Deepak K Somashekar, Benjamin L Viglianti, Hero K Hussain.   

Abstract

PURPOSE: To determine for expert and novice radiologists repeatability of major diagnostic features and scoring systems (ie, Liver Imaging Reporting and Data System [LI-RADS], Organ Procurement and Transplantation Network [OPTN], and American Association for the Study of Liver Diseases [AASLD]) for hepatocellular carcinoma (HCC) by using magnetic resonance (MR) imaging.
MATERIALS AND METHODS: Institutional review board approval was obtained and patient consent was waived for this HIPAA-compliant, retrospective study. The LI-RADS discussed in this article refers to version 2013.1. Ten blinded readers reviewed 100 liver MR imaging studies that demonstrated observations preliminarily assigned LI-RADS scores of LR1-LR5. Diameter and major HCC features (arterial hyperenhancement, washout appearance, pseudocapsule) were recorded for each observation. LI-RADS, OPTN, and AASLD scores were assigned. Interreader agreement was assessed by using intraclass correlation coefficients and κ statistics. Scoring rates were compared by using McNemar test.
RESULTS: Overall interreader agreement was substantial for arterial hyperenhancement (0.67 [95% confidence interval {CI}: 0.65, 0.69]), moderate for washout appearance (0.48 [95%CI: 0.46, 0.50]), moderate for pseudocapsule (0.52 [95% CI: 050, 0.54]), fair for LI-RADS (0.35 [95% CI: 0.34, 0.37]), fair for AASLD (0.39 [95% CI: 0.37, 0.42]), and moderate for OPTN (0.53 [95% CI: 0.51, 0.56]). Agreement for measured diameter was almost perfect (range, 0.95-0.97). There was substantial agreement for most scores consistent with HCC. Experts agreed significantly more than did novices and were significantly more likely than were novices to assign a diagnosis of HCC (P < .001).
CONCLUSION: Two of three major features for HCC (washout appearance and pseudocapsule) have only moderate interreader agreement. Experts and novices who assigned scores consistent with HCC had substantial but not perfect agreement. Expert agreement is substantial for OPTN, but moderate for LI-RADS and AASLD. Novices were less consistent and less likely to diagnose HCC than were experts. © RSNA, 2014.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24555636      PMCID: PMC4263627          DOI: 10.1148/radiol.14131963

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Understanding interobserver agreement: the kappa statistic.

Authors:  Anthony J Viera; Joanne M Garrett
Journal:  Fam Med       Date:  2005-05       Impact factor: 1.756

Review 2.  Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience.

Authors:  Vincenzo Mazzaferro; Sherrie Bhoori; Carlo Sposito; Marco Bongini; Martin Langer; Rosalba Miceli; Luigi Mariani
Journal:  Liver Transpl       Date:  2011-10       Impact factor: 5.799

3.  New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma.

Authors:  Christoph Wald; Mark W Russo; Julie K Heimbach; Hero K Hussain; Elizabeth A Pomfret; Jordi Bruix
Journal:  Radiology       Date:  2013-02       Impact factor: 11.105

4.  Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.

Authors:  Elizabeth A Pomfret; Kenneth Washburn; Christoph Wald; Michael A Nalesnik; David Douglas; Mark Russo; John Roberts; David J Reich; Myron E Schwartz; Luis Mieles; Fred T Lee; Sander Florman; Francis Yao; Ann Harper; Erick Edwards; Richard Freeman; John Lake
Journal:  Liver Transpl       Date:  2010-03       Impact factor: 5.799

5.  Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

Authors:  Pierre-Alain Clavien; Mickael Lesurtel; Patrick M M Bossuyt; Gregory J Gores; Bernard Langer; Arnaud Perrier
Journal:  Lancet Oncol       Date:  2011-10-31       Impact factor: 41.316

Review 6.  MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.

Authors:  Jonathon M Willatt; Hero K Hussain; Saroja Adusumilli; Jorge A Marrero
Journal:  Radiology       Date:  2008-05       Impact factor: 11.105

7.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

8.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Authors:  V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 176.079

  8 in total
  43 in total

1.  Longitudinal evolution of CT and MRI LI-RADS v2014 category 1, 2, 3, and 4 observations.

Authors:  Cheng William Hong; Charlie C Park; Adrija Mamidipalli; Jonathan C Hooker; Soudabeh Fazeli Dehkordy; Saya Igarashi; Mohanad Alhumayed; Yuko Kono; Rohit Loomba; Tanya Wolfson; Anthony Gamst; Paul Murphy; Claude B Sirlin
Journal:  Eur Radiol       Date:  2019-02-26       Impact factor: 5.315

2.  The need for standardization of nuclear cardiology reporting and data system (NCAD-RADS): Learning from coronary artery disease (CAD), breast imaging (BI), liver imaging (LI), and prostate imaging (PI) RADS.

Authors:  Majid Assadi; Erik Velez; Mohammad Hosein Najafi; Ali Gholamrezanezhad
Journal:  J Nucl Cardiol       Date:  2018-10-29       Impact factor: 5.952

3.  Performance of Gd-EOB-DTPA-enhanced MRI for the diagnosis of LI-RADS 4 category hepatocellular carcinoma nodules with different diameters.

Authors:  Qi Tang; Cong Ma
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

4.  Risk Factors and Center-Level Variation in Hepatocellular Carcinoma Under-Staging for Liver Transplantation.

Authors:  Nadim Mahmud; Maarouf A Hoteit; David S Goldberg
Journal:  Liver Transpl       Date:  2020-08       Impact factor: 5.799

Review 5.  Pitfalls and problems to be solved in the diagnostic CT/MRI Liver Imaging Reporting and Data System (LI-RADS).

Authors:  Yeun-Yoon Kim; Jin-Young Choi; Claude B Sirlin; Chansik An; Myeong-Jin Kim
Journal:  Eur Radiol       Date:  2018-08-16       Impact factor: 5.315

6.  Evaluation of LI-RADS 3 category by magnetic resonance in US-detected nodules ≤ 2 cm in cirrhotic patients.

Authors:  Anna Darnell; Jordi Rimola; Ernest Belmonte; Enric Ripoll; Ángeles Garcia-Criado; Carla Caparroz; Álvaro Díaz-González; Ramón Vilana; María Reig; Carmen Ayuso; Jordi Bruix; Alejandro Forner
Journal:  Eur Radiol       Date:  2021-01-06       Impact factor: 5.315

7.  Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists.

Authors:  Andrew B Rosenkrantz; Luke A Ginocchio; Daniel Cornfeld; Adam T Froemming; Rajan T Gupta; Baris Turkbey; Antonio C Westphalen; James S Babb; Daniel J Margolis
Journal:  Radiology       Date:  2016-04-01       Impact factor: 11.105

8.  Deep convolutional neural network applied to the liver imaging reporting and data system (LI-RADS) version 2014 category classification: a pilot study.

Authors:  Rikiya Yamashita; Amber Mittendorf; Zhe Zhu; Kathryn J Fowler; Cynthia S Santillan; Claude B Sirlin; Mustafa R Bashir; Richard K G Do
Journal:  Abdom Radiol (NY)       Date:  2020-01

9.  Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI.

Authors:  Scott M Thompson; Ishan Garg; Eric C Ehman; Shannon P Sheedy; Candice A Bookwalter; Rickey E Carter; Lewis R Roberts; Sudhakar K Venkatesh
Journal:  Br J Radiol       Date:  2018-08-29       Impact factor: 3.039

10.  Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.

Authors:  Eric C Ehman; Spencer C Behr; Sarah E Umetsu; Nicholas Fidelman; Ben M Yeh; Linda D Ferrell; Thomas A Hope
Journal:  Abdom Radiol (NY)       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.